Viewing Study NCT00978250


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-02-28 @ 12:02 AM
Study NCT ID: NCT00978250
Status: COMPLETED
Last Update Posted: 2019-12-27
First Post: 2009-09-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-08-20
Start Date Type: ACTUAL
Primary Completion Date: 2019-04-11
Primary Completion Date Type: ACTUAL
Completion Date: 2019-04-11
Completion Date Type: ACTUAL
First Submit Date: 2009-09-15
First Submit QC Date: None
Study First Post Date: 2009-09-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-12-12
Results First Submit QC Date: None
Results First Post Date: 2019-12-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-12-12
Last Update Post Date: 2019-12-27
Last Update Post Date Type: ACTUAL